AFT Pharmaceuticals Limited

AFT Pharmaceuticals develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and globally. The company offers proprietary and in-licensed products, including patented, branded, and generic drugs

Products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, natural health, pain management, skin care, sleeping aids, supplements, and products.

It has a R&D collaboration with Hyloris Pharmaceuticals SA for the development of the Maxigesic IV product. Incorporated in 1997, AFT Pharmaceuticals is headquartered in Auckland, New Zealand.